Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Elizabeth Swisher, University of Washington Identifier:
First received: February 28, 2012
Last updated: April 10, 2017
Last verified: October 2016
The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.

Ovarian Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study

Resource links provided by NLM:

Further study details as provided by University of Washington:

Primary Outcome Measures:
  • Describe subject experience in undergoing Salpingectomy as a means of riks reduction [ Time Frame: At conclusion of study ]
    Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure

Enrollment: 24
Study Start Date: December 2011
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Fallopian tube removal
Women who have had one or both fallopian tube(s) removed as method of ovarian cancer prevention.

Detailed Description:
Women will be found eligible for this study after an eligibility questionnaire given over the phone. If one is found eligible, she will be sent a consent and paper survey to fill out and send back to the research coordinator. Once that is completed, she will be given a phone interview in order answer additional questions of interest. Lastly, the study participant will be contacted once a year over the phone to obtain follow-up information.

Ages Eligible for Study:   18 Years to 100 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women who have had their fallopian tubes removed as a method of ovarian cancer prevention.

Inclusion Criteria:

  • Female of at least 18 years of age
  • Must speak English fluently
  • Have had fallopian tubes removed as a method of ovarian cancer prevention

Exclusion Criteria:

  • Males
  • Females under the age of 18
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01544049

United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
Principal Investigator: Elizabeth Swisher, MD University of Washington
  More Information

Responsible Party: Elizabeth Swisher, Professor, University of Washington Identifier: NCT01544049     History of Changes
Other Study ID Numbers: 41774-G
Study First Received: February 28, 2012
Last Updated: April 10, 2017

Keywords provided by University of Washington:
fallopian tube removal
ovarian cancer prevention

Additional relevant MeSH terms:
Ovarian Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders processed this record on May 25, 2017